Skip to main content

Meet MGC Diagnostics

Since 1977, we’ve been dedicated to cardiorespiratory health solutions.

Headquartered in Saint Paul, Minnesota, USA, MGC Diagnostics Corporation, develops, manufactures and markets non-invasive diagnostic systems for detecting, classifying and managing cardiorespiratory disease.

This singular focus guides our strategy and defines our commitment to customers, employees and the cardiorespiratory industry. Our experience provides unmatched insight for solving today’s challenges and anticipating tomorrow’s opportunities.

It all starts with why…

Chronic Obstructive Pulmonary Disease (COPD) is a progressive and chronic disease. 

As the third leading cause of death in the world, it is estimated that over 300 million people worldwide have COPD and deaths are expected to increase 30% in the next 10 years.*

*Eur J Epidemiol. 2016; 31(8): 785–792.

We are passionate about developing powerful and accurate devices to assist in the diagnosis of respiratory disease and ensuring the information obtained benefits the disease management process.

Quick Facts

Founded

1977

Locations

5

Global Employees

215

Active Devices Worldwide

15K+

 

Each MGC Diagnostics client receives individual attention that’s customized and comprehensive. Our simple approach has endured: Integrate the latest advances that today’s technology affords, ensure accuracy through superior design, and then back up each and every product with consistently stellar support. We don’t just stand by our product; we stand by our customers.

Our History

1977

Founded by Catherine (Kye) A. Anderson.

Space Program Testing: NASA’s Johnson Space Center in Houston relies on our Breath-by-Breath gas exchange measurement with the System 2000.

MGC System 2000: exercise system and KEM 2 cycle ergometer.

1983

CAD/NET™ System 2001: assisted an international pharmaceutical firm in evaluating the effectiveness of a new drug based on preventing certain forms of heart disease.

1985 World’s Fair in Japan: Pulmonary Consult™ was inducted, a sophisticated software program based on algorithms from the principles of artificial intelligence.

1989

Flow Meter System: Branded the preVent™ flow sensor, the foundation of every MGC Diagnostics Product. This product, with some modifications, is still in use today.

PF/DX System: A mobile system capable of performing beside PFT testing. 

CCM/D and CPX/D: upgraded from the DOS operating system to BreezeEx, expanding functionality and improving ease of use.

1996

Gold Standard:  rated industry leader in customer service by a nationally renowned independent consulting firm.

Ultima Series: CCM/D, CPX/D, and CardiO2 were all upgraded.

Profiler™: combines spirometry, lung volumes and diffusing capacity to give complete testing capabilities.

2007

BreezeSuite™: application software designed to combine gas exchange and pulmonary function testing, setting a new standard for ease-of-use.

BreezeSuite WebReview™: workflow solution designed to expedite remote access to test data

BreezeConnect™ network connection and interfacing to stored cardiorespiratory diagnostic information across multiple testing systems and review stations.

2013

Rebranded to the MGC Diagnostics you know today. 

Ultima Series: latest design of the Ultima Series™ cardiorespiratory diagnostic systems, capable of performing both pulmonary function and metabolic testing in a singular, modular, and upgradeable platform.

Medisoft SA: acquisition of Belgium-based company significantly expands business internationally.

2016

Resmon PRO FULL: Entered into an exclusive distribution partnership with ResTech Respiratory Technology for the Resmon PRO™ FULL FOT system for Forced Oscillation Technique.

Scientific Advisory Committee: formed committee comprised of physicians and scientists to assist in providing advice and guidance on medical and scientific matters related to our business.

Altus Capital Partners: acquisition moves MGCD to a private company and supports the company’s strategies for product innovation and growth.

2019

MSE Medical: acquisition of France-based MSE Medical expands French market and becomes MGC Diagnostics France.

Ascencia: acquisition of Australia-based Ascencia expands South Pacific market and becomes MGC Diagnostics Australia.

2020

Ascent™: cardiorespiratory diagnostic software, designed from the ground up, results in the most advanced testing software platform available

Our Offices

Mulgrave, Australia

MGC Diagnostics Australia (formerly Ascencia)

Dinant, Belgium

MGC Diagnostics International (currently Medisoft)

France

MGC Diagnostics France (formerly MSE Medical)

Saint Paul, Minnesota

MGC Diagnostics Corporation (headquarters)

Career Opportunities

Looking for your next career move? We are always looking for like-minded individuals to join our team.

Careers